69 related articles for article (PubMed ID: 15824731)
1. Impact of PKCdelta on estrogen receptor localization and activity in breast cancer cells.
De Servi B; Hermani A; Medunjanin S; Mayer D
Oncogene; 2005 Jul; 24(31):4946-55. PubMed ID: 15824731
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor alpha.
Barry JB; Giguère V
Cancer Res; 2005 Jul; 65(14):6120-9. PubMed ID: 16024613
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
4. Involvement of protein kinase Cdelta in contact-dependent inhibition of growth in human and murine fibroblasts.
Heit I; Wieser RJ; Herget T; Faust D; Borchert-Stuhlträger M; Oesch F; Dietrich C
Oncogene; 2001 Aug; 20(37):5143-54. PubMed ID: 11526503
[TBL] [Abstract][Full Text] [Related]
5. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
6. PKCdelta associates with and is involved in the phosphorylation of RasGRP3 in response to phorbol esters.
Brodie C; Steinhart R; Kazimirsky G; Rubinfeld H; Hyman T; Ayres JN; Hur GM; Toth A; Yang D; Garfield SH; Stone JC; Blumberg PM
Mol Pharmacol; 2004 Jul; 66(1):76-84. PubMed ID: 15213298
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
[TBL] [Abstract][Full Text] [Related]
8. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor-2 and TPA enhance prostate-cancer-cell proliferation and activate members of the Ras and PKC signal transduction pathways.
Hrzenjak M; Shain SA
Recept Signal Transduct; 1997; 7(4):207-19. PubMed ID: 9633822
[TBL] [Abstract][Full Text] [Related]
11. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
[TBL] [Abstract][Full Text] [Related]
12. Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer.
Kim JW; Akiyama M; Park JH; Lin ML; Shimo A; Ueki T; Daigo Y; Tsunoda T; Nishidate T; Nakamura Y; Katagiri T
Cancer Sci; 2009 Aug; 100(8):1468-78. PubMed ID: 19496786
[TBL] [Abstract][Full Text] [Related]
13. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C delta involvement in mammary tumor cell metastasis.
Kiley SC; Clark KJ; Goodnough M; Welch DR; Jaken S
Cancer Res; 1999 Jul; 59(13):3230-8. PubMed ID: 10397270
[TBL] [Abstract][Full Text] [Related]
15. Activation and translocation of PKCdelta is necessary for VEGF-induced ERK activation through KDR in HEK293T cells.
Kuriyama M; Taniguchi T; Shirai Y; Sasaki A; Yoshimura A; Saito N
Biochem Biophys Res Commun; 2004 Dec; 325(3):843-51. PubMed ID: 15541367
[TBL] [Abstract][Full Text] [Related]
16. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
17. Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCdelta-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation.
Vucenik I; Ramakrishna G; Tantivejkul K; Anderson LM; Ramljak D
Breast Cancer Res Treat; 2005 May; 91(1):35-45. PubMed ID: 15868430
[TBL] [Abstract][Full Text] [Related]
18. Neutral endopeptidase promotes phorbol ester-induced apoptosis in prostate cancer cells by inhibiting neuropeptide-induced protein kinase C delta degradation.
Sumitomo M; Shen R; Goldberg JS; Dai J; Navarro D; Nanus DM
Cancer Res; 2000 Dec; 60(23):6590-6. PubMed ID: 11118039
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol-3-OH Kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor alpha (ERalpha) via interaction between ERalpha and PI3K.
Sun M; Paciga JE; Feldman RI; Yuan Z; Coppola D; Lu YY; Shelley SA; Nicosia SV; Cheng JQ
Cancer Res; 2001 Aug; 61(16):5985-91. PubMed ID: 11507039
[TBL] [Abstract][Full Text] [Related]
20. Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells.
Shah N; Thomas TJ; Lewis JS; Klinge CM; Shirahata A; Gelinas C; Thomas T
Oncogene; 2001 Mar; 20(14):1715-29. PubMed ID: 11313919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
